Novavax
NVAX
#5862
Rank
โ‚น124.01 B
Marketcap
โ‚น751.84
Share price
-0.75%
Change (1 day)
6.80%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -โ‚น6.08 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น0.59 Billion. In 2025 the company made an earning of โ‚น44.28 Billion, an increase over its 2024 earnings that were of -โ‚น14.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น6.08 Billion-113.72%
2025 โ‚น44.28 B-396.87%
2024 -โ‚น14.92 Billion-70.39%
2023 -โ‚น50.38 Billion-16.59%
2022 -โ‚น60.4 Billion-62.58%
2021 -โ‚น161.4 Billion320.54%
2020 -โ‚น38.38 Billion234.22%
2019 -โ‚น11.49 Billion-30.17%
2018 -โ‚น16.45 Billion1.69%
2017 -โ‚น16.18 Billion-36.44%
2016 -โ‚น25.45 Billion70.4%
2015 -โ‚น14.94 Billion89.27%
2014 -โ‚น7.89 Billion59.83%
2013 -โ‚น4.94 Billion81.9%
2012 -โ‚น2.72 Billion50.33%
2011 -โ‚น1.81 Billion
2009 -โ‚น3.57 Billion8.8%
2008 -โ‚น3.28 Billion18.01%
2007 -โ‚น2.78 Billion18.33%
2006 -โ‚น2.35 Billion168.31%
2005 -โ‚น0.88 Billion-62.51%
2004 -โ‚น2.34 Billion52.4%
2003 -โ‚น1.53 Billion-28.21%
2002 -โ‚น2.14 Billion
2000 -โ‚น1.22 Billion177%
1999 -โ‚น0.44 Billion-11.54%
1998 -โ‚น0.5 Billion10.64%
1997 -โ‚น0.45 Billion-9.62%
1996 -โ‚น0.5 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.504 T-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.009 T-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.397 T-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น953.98 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น2.33 B-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น29.46 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น11.40 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.78 Billion-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น43.28 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น5.63 B-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA